A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population
- PMID: 22493738
- PMCID: PMC3320879
- DOI: "VSports" 10.1371/journal.pone.0035145
A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population (V体育ios版)
Abstract
Background: Recently, several studies have demonstrated that two long non-coding RNAs (lncRNAs), HULC and MALAT1, may participate in hepatocellular carcinoma (HCC) development and progression. However, genetic variations in the two lncRNAs and their associations with HCC susceptibility have not been reported. In this study, we hypothesized that single nucleotide polymorphisms (SNPs) in HULC and MALAT1 may contribute to HCC risk. VSports手机版.
Methods: We conducted a case-control study and genotyped two SNPs, rs7763881 in HULC and rs619586 in MALAT1, in 1300 HBV positive HCC patients, 1344 HBV persistent carriers and 1344 subjects with HBV natural clearance to test the associations between the two SNPs and susceptibility to HCC and HBV chronic infection V体育安卓版. .
Results: The variant genotypes of rs7763881 were significantly associated with decreased HCC risk in a dominant genetic model [AC/CC vs. AA: adjusted odds ration (OR) = 0. 81, 95% confidence intervals (CIs) = 0. 68-0. 97, P = 0. 022]. Furthermore, the variant genotypes of rs619586 was associated with decreased HCC risk with a borderline significance (AG/GG vs. AA: adjusted OR = 0. 81, 95% CIs = 0. 65-1 V体育ios版. 01, P = 0. 057). However, no significant association was found between the two SNPs and HBV clearance. .
Conclusions: The variant genotypes of rs7763881 in HULC may contribute to decreased susceptibility to HCC in HBV persistent carriers. VSports最新版本.
Conflict of interest statement
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
-
- Walter SR, Thein HH, Gidding HF, Amin J, Law MG, et al. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or hepatitis C. J Gastroenterol Hepatol. 2011. - PubMed
-
- Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–458. - "V体育ios版" PMC - PubMed
-
- Song IH, Kim KS. Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol. 2009;15(Suppl 6):S50–59. - PubMed
-
- Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286:9–14. - PubMed
Publication types
- V体育平台登录 - Actions
MeSH terms
- "V体育2025版" Actions
- V体育安卓版 - Actions
- "V体育官网入口" Actions
- Actions (V体育官网入口)
- V体育官网入口 - Actions
- Actions (VSports在线直播)
- VSports在线直播 - Actions
- Actions (V体育2025版)
Substances (V体育2025版)
- "V体育ios版" Actions
- VSports - Actions
- "V体育官网入口" Actions
VSports在线直播 - LinkOut - more resources
Full Text Sources
Other Literature Sources (V体育平台登录)
"VSports注册入口" Medical
